Exploring the pathogenesis underlying development of bronchopulmonary dysplasia in preterm infants using serum multi-proteomics

INTRODUCTION: The increasing incidence and lack of effective strategies for the prevention of bronchopulmonary dysplasia (BPD) in preterm infants underlines the need to gain further insight into molecular changes associated with the development of this condition. AIM: To quantify serum protein levels in preterm infants (<30 weeks gestational age (GA)) associated with molecular mechanisms underlying BPD development. METHODS: Serum samples, collected at birth, day 3, 7, and 14, of 64 preterm infants (of whom 18 were diagnosed with BPD) were analyzed using proteomic approaches. RESULTS: Cross-sectional statistical analysis revealed the levels of 80 out of 665 quantified proteins differed between the infants with and without BPD, with most alterations found on day 3 (n = 59) and day 7 (n = 40). Notably, the majority of proteins were decreased in infants developing BPD. Alterations included growth factors (e.g., insulin like growth factor (IGF) pathway components), immunoglobulins, and circulating blood cell-derived proteins, alongside a clear cytokine disruption. CONCLUSION: The affected pathways underscore the broad dysregulation of processes besides inflammation in preterm infants who developed BPD. These findings may provide a basis for studies searching for alternative therapeutic targets to prevent BPD. IMPACT: The incidence of bronchopulmonary dysplasia (BPD) in preterm infants is increasing. Multi-proteomic analysis of longitudinal serum samples in the first two weeks after birth can identify molecular changes associated with BPD development. The majority of proteins levels were decreased in preterm infants who developed BPD with most pronounced differences at day 3 and day 7 Alterations were observed in levels of cytokines, insulin-like growth factor related proteins, immunoglobulins as well as circulating blood-cell-derived protein signatures. This study highlights molecular alterations beyond inflammation and suggests a broader change in molecular processes related to systemic communication.

Authors

Institutions

Publication Details

Journal
Pediatric Research
Published
2026-11-14
DOI
https://doi.org/10.1038/s41390-026-05542-y
Primary Topic
Neonatal Respiratory Health Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exploring the pathogenesis underlying development of bronchopulmonary dysplasia in preterm infants using serum multi-proteomics

Pieter Langerhorst, Joost Rotteveel, Martijn J.J. Finken, Michelle Romijn et al.
1 links
Pediatric Research
Neonatal Respiratory Health Research
article

Exploring the pathogenesis underlying development of bronchopulmonary dysplasia in preterm infants using serum multi-proteomics

Pieter Langerhorst, Joost Rotteveel, Martijn J.J. Finken, Michelle Romijn, Maartje van den Biggelaar, Wes Onland, Anton H. van Kaam, Charlotte Teunissen E, Eva R. Smit, Minke van Tuyl
article en

Abstract

INTRODUCTION: The increasing incidence and lack of effective strategies for the prevention of bronchopulmonary dysplasia (BPD) in preterm infants underlines the need to gain further insight into molecular changes associated with the development of this condition. AIM: To quantify serum protein levels in preterm infants (<30 weeks gestational age (GA)) associated with molecular mechanisms underlying BPD development. METHODS: Serum samples, collected at birth, day 3, 7, and 14, of 64 preterm infants (of whom 18 were diagnosed with BPD) were analyzed using proteomic approaches. RESULTS: Cross-sectional statistical analysis revealed the levels of 80 out of 665 quantified proteins differed between the infants with and without BPD, with most alterations found on day 3 (n = 59) and day 7 (n = 40). Notably, the majority of proteins were decreased in infants developing BPD. Alterations included growth factors (e.g., insulin like growth factor (IGF) pathway components), immunoglobulins, and circulating blood cell-derived proteins, alongside a clear cytokine disruption. CONCLUSION: The affected pathways underscore the broad dysregulation of processes besides inflammation in preterm infants who developed BPD. These findings may provide a basis for studies searching for alternative therapeutic targets to prevent BPD. IMPACT: The incidence of bronchopulmonary dysplasia (BPD) in preterm infants is increasing. Multi-proteomic analysis of longitudinal serum samples in the first two weeks after birth can identify molecular changes associated with BPD development. The majority of proteins levels were decreased in preterm infants who developed BPD with most pronounced differences at day 3 and day 7 Alterations were observed in levels of cytokines, insulin-like growth factor related proteins, immunoglobulins as well as circulating blood-cell-derived protein signatures. This study highlights molecular alterations beyond inflammation and suggests a broader change in molecular processes related to systemic communication.

Pediatric Research
Amsterdam UMC Location University of Amsterdam (NL), Sanquin (NL), Amsterdam Neuroscience (NL), Amsterdam Reproduction Development (NL), Vrije Universiteit Amsterdam (NL), Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Landsteiner Foundation for Blood Transfusion Research
Good health and well-being
Neonatal Respiratory Health Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon